☰

Todd E. Meyerrose, Ph.D. - Publications

Affiliations: 
2007 Washington University, Saint Louis, St. Louis, MO 
Area:
Cell Biology
Tree Info Grants Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2010 Meyerrose T, Olson S, Pontow S, Kalomoiris S, Jung Y, Annett G, Bauer G, Nolta JA. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Advanced Drug Delivery Reviews. 62: 1167-74. PMID 20920540 DOI: 10.1016/J.Addr.2010.09.013  0.524
2008 Bauer G, Dao MA, Case SS, Meyerrose T, Wirthlin L, Zhou P, Wang X, Herrbrich P, Arevalo J, Csik S, Skelton DC, Walker J, Pepper K, Kohn DB, Nolta JA. In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1308-15. PMID 18461052 DOI: 10.1182/Blood.V110.11.2595.2595  0.42
2008 Meyerrose TE, Roberts M, Ohlemiller KK, Vogler CA, Wirthlin L, Nolta JA, Sands MS. Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells (Dayton, Ohio). 26: 1713-22. PMID 18436861 DOI: 10.1634/Stemcells.2008-0008  0.55
2007 Partlow KC, Chen J, Brant JA, Neubauer AM, Meyerrose TE, Creer MH, Nolta JA, Caruthers SD, Lanza GM, Wickline SA. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 1647-54. PMID 17284484 DOI: 10.1096/Fj.06-6505Com  0.461
2007 Meyerrose TE, De Ugarte DA, Hofling AA, Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands MS, Hedrick MA, Nolta JA. In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells (Dayton, Ohio). 25: 220-7. PMID 16960135 DOI: 10.1634/Stemcells.2006-0243  0.563
2005 Wirthlin L, Meyerrose TE, Creer MH, Nolta JA. Involvement of Lipid Raft Domain Signaling in Ex Vivo Maintenance of Hematopoietic Progenitor Cells. Blood. 106: 4216-4216. DOI: 10.1182/Blood.V106.11.4216.4216  0.552
2005 Rosova I, Meyerrose TE, Nolta JA. Working Toward Better Tissue Repair Therapies: Exposure of MSC to Hypoxic Conditions In Vitro Increases Levels of the Hepatocyte Growth Factor Receptor c-met, Improves Motility, and Induces Phosphorylation of the Pro-Survival Protein AKT. Blood. 106: 2313-2313. DOI: 10.1182/Blood.V106.11.2313.2313  0.525
2005 Herrbrich PE, Meyerrose TE, Nolta JA. Exploring the Molecular Mechanisms for Enhancing MSC Homing and Lodgement within Sites of Liver Damage/Fibrosis. Blood. 106: 1690-1690. DOI: 10.1182/Blood.V106.11.1690.1690  0.617
2005 Meyerrose TE, Smith E, Nolta JA, Frenkel B. 1121. Osteogenic Growth Peptide Preferentially Enhances Trabecular Bone Mass Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.669  0.313
2005 Meyerrose TE, Herrbrich PE, Creer MH, Nolta JA. 1037. Adherent Human Umbilical Cord Blood Derived Mesenchymal Stem Cells Do Not Augment Viral Gene Transfer into Hematopoietic Stem/Progenitor Cells Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.584  0.537
2005 Meyerrose TE, Herrbrich PE, Creer MH, Nolta JA. 1032. Hepatocyte Growth Factor Maintains Hematopoietic Progenitors during Retroviral Transduction Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.579  0.534
2005 Nervi B, Rettig MP, Ritchey JK, Bauer G, Walker J, Herrbrich PE, Meyerrose TE, Bonyhadi M, Nolta JA, DiPersio JF. 810. Ex-Vivo Activation and Genetic Manipulation of Human T Cells Results in Consistent In-Vivo Expansion and Lethal GvHD in a Novel Murine Xenotransplant Model Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.347  0.42
2005 Hope A, Meyerrose TE, Nolta JA. 353. Retrovirally-Marked Human Bone Marrow Derived Mesenchymal Stem Cells Attenuate Radiation Induced Pneumonitis in a Xenotransplant Model Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.356  0.467
2005 Herrbrich PE, Meyerrose TE, Hofling AA, Sands M, Nolta JA. 243. Transplantation of Neonatal NOD/SCID/MPSVII Mice with Human Mesenchymal Stem Cells Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.246  0.569
2004 Xu L, O'Malley T, Sands MS, Wang B, Meyerrose T, Haskins ME, Ponder KP. In vivo transduction of hematopoietic stem cells after neonatal intravenous injection of an amphotropic retroviral vector in mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 37-44. PMID 15233940 DOI: 10.1016/J.Ymthe.2004.04.010  0.532
2004 Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, Creer MH, Nolta JA. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood. 104: 1648-55. PMID 15178579 DOI: 10.1182/Blood-2004-02-0448  0.554
2004 Hess DA, Wirthlin L, Craft TP, Meyerrose TE, Nolta JA. CD133-Expressing Cells with High Aldehyde Dehydrogenase Activity Represent a Primitive Human Hematopoietic Stem Cell Population with Enhanced Repopulating Potential. Blood. 104: 250-250. DOI: 10.1182/Blood.V104.11.250.250  0.438
2004 Hess DA, Meyerrose TE, Wirthlin L, Herrbrich PE, Craft TP, Nolta JA. 898. Human hematopoietic repopulating stem and progenitor cells can be efficiently selected based on high aldehyde dehydrogenase activity Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.804  0.527
2004 Walker JE, Bauer G, Herrbrich P, Hess D, Meyerrose T, Nervi B, Rettig M, Nolta JA, DiPersio JF. 606. The NOD-SCID |[beta]|2M null mouse xenograft model for studying activation, expansion and GvHD potential of gene transduced human t cells in vivo Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.1010  0.445
2003 Meyerrose TE, Herrbrich P, Hess DA, Nolta JA. Immune-deficient mouse models for analysis of human stem cells. Biotechniques. 35: 1262-72. PMID 14682062 DOI: 10.2144/03356Ss06  0.549
2003 Rettig MP, Ritchey JK, Meyerrose TE, Haug JS, DiPersio JF. Transduction and selection of human T cells with novel CD34/thymidine kinase chimeric suicide genes for the treatment of graft-versus-host disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 29-41. PMID 12842426 DOI: 10.1016/S1525-0016(03)00142-4  0.374
2002 Gussoni E, Bennett RR, Muskiewicz KR, Meyerrose T, Nolta JA, Gilgoff I, Stein J, Chan YM, Lidov HG, Bönnemann CG, Von Moers A, Morris GE, Den Dunnen JT, Chamberlain JS, Kunkel LM, et al. Long-term persistence of donor nuclei in a Duchenne muscular dystrophy patient receiving bone marrow transplantation. The Journal of Clinical Investigation. 110: 807-14. PMID 12235112 DOI: 10.1172/Jci16098  0.37
2001 Szilvassy SJ, Meyerrose TE, Ragland PL, Grimes B. Homing and engraftment defects in ex vivo expanded murine hematopoietic cells are associated with downregulation of beta1 integrin. Experimental Hematology. 29: 1494-502. PMID 11750109 DOI: 10.1016/S0301-472X(01)00751-2  0.494
2001 Szilvassy SJ, Meyerrose TE, Ragland PL, Grimes B. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood. 98: 2108-15. PMID 11567997 DOI: 10.1182/Blood.V98.7.2108  0.58
2000 Jordan CT, Upchurch D, Szilvassy SJ, Guzman ML, Howard DS, Pettigrew AL, Meyerrose T, Rossi R, Grimes B, Rizzieri DA, Luger SM, Phillips GL. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia. 14: 1777-84. PMID 11021753 DOI: 10.1038/Sj.Leu.2401903  0.428
2000 de Haan G, Szilvassy SJ, Meyerrose TE, Dontje B, Grimes B, Van Zant G. Distinct functional properties of highly purified hematopoietic stem cells from mouse strains differing in stem cell numbers. Blood. 96: 1374-9. PMID 10942380 DOI: 10.1182/Blood.V96.4.1374.H8001374_1374_1379  0.553
2000 Szilvassy SJ, Meyerrose TE, Grimes B. Effects of cell cycle activation on the short-term engraftment properties of ex vivo expanded murine hematopoietic cells. Blood. 95: 2829-37. PMID 10779428 DOI: 10.1182/Blood.V95.9.2829.009K37_2829_2837  0.534
Show low-probability matches.